HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cuimiao Zheng Selected Research

DNA (Deoxyribonucleic Acid)

12/2022Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cuimiao Zheng Research Topics

Disease

3Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 01/2022
2Neoplasms (Cancer)
01/2023 - 12/2022
1Ovarian Epithelial Carcinoma
11/2023

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
12/2022 - 01/2022
2PlatinumIBA
12/2022 - 01/2022
1EnzymesIBA
11/2023
1fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA
11/2023
1Tyrosine (L-Tyrosine)FDA Link
11/2023
1Lipid NanoparticlesIBA
01/2023
1adavosertibIBA
01/2023
1Small Interfering RNA (siRNA)IBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
12/2022
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
12/2022
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2023 - 12/2022